Home › Compare › ARUXF vs BTI

ARUXF vs BTI: Dividend Comparison 2026

ARUXF yields 44444.44% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARUXF wins by $1.4802188700273396e+23M in total portfolio value
10 years
ARUXF
ARUXF
● Live price
44444.44%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4802188700273396e+23M
Annual income
$147,369,615,738,581,320,000,000,000,000.00
Full ARUXF calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — ARUXF vs BTI

📍 ARUXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARUXFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARUXF + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ARUXF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARUXF
Annual income on $10K today (after 15% tax)
$3,777,777.78/yr
After 10yr DRIP, annual income (after tax)
$125,264,173,377,794,110,000,000,000,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, ARUXF beats the other by $125,264,173,377,794,110,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARUXF + BTI for your $10,000?

ARUXF: 50%BTI: 50%
100% BTI50/50100% ARUXF
Portfolio after 10yr
$7.401094350136698e+22M
Annual income
$73,684,807,869,290,660,000,000,000,000.00/yr
Blended yield
99.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

ARUXF
No analyst data
Altman Z
-46.1
Piotroski
3/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARUXF buys
0
BTI buys
0
No recent congressional trades found for ARUXF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARUXFBTI
Forward yield44444.44% ✓5.38%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$1.4802188700273396e+23M$37.7K ✓
Annual income after 10y$147,369,615,738,581,320,000,000,000,000.00 ✓$2,786.64
Total dividends collected$1.4797905017086652e+23M$14.3K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: ARUXF vs BTI ($10,000, DRIP)

YearARUXF PortfolioARUXF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$4,455,144$4,444,444.44$11,299$598.92+$4.44M → ARUXF
2$1,855,294,292$1,850,527,287.41$12,794$703.91+$1855.28M → ARUXF
3$722,201,114,647$720,215,949,754.98$14,518$829.07+$722201.10M → ARUXF
4$262,786,638,114,837$262,013,882,922,164.10$16,513$978.64+$262786638.10M → ARUXF
5$89,382,811,928,504,960$89,101,630,225,722,080.00$18,827$1,157.84+$89382811928.49M → ARUXF
6$28,419,510,536,946,614,000$28,323,870,928,183,110,000.00$21,518$1,373.12+$28419510536946.59M → ARUXF
7$8,446,906,587,814,894,000,000$8,416,497,711,540,360,000,000.00$24,657$1,632.46+$8446906587814894.00M → ARUXF
8$2,346,953,255,508,951,600,000,000$2,337,915,065,459,989,300,000,000.00$28,329$1,945.74+$2346953255508951552.00M → ARUXF
9$609,599,312,292,179,560,000,000,000$607,088,072,308,785,000,000,000,000.00$32,637$2,325.33+$609599312292179607552.00M → ARUXF
10$148,021,887,002,733,950,000,000,000,000$147,369,615,738,581,320,000,000,000,000.00$37,708$2,786.64+$1.4802188700273396e+23M → ARUXF

ARUXF vs BTI: Complete Analysis 2026

ARUXF — Stock

Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated in 1998 and is based in West Melbourne, Australia.

Full ARUXF Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this ARUXF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARUXF vs SCHDARUXF vs JEPIARUXF vs OARUXF vs KOARUXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.